Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,103,997
-$170,646 QoQ
Shares Held
59,214
-0.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.91%
of 13F equity value
Holder Rank
#196
of 1,033 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AIMZ Investment Advisors, LLC holds $37,637,360 across 11 Drug Manufacturers - General names. GSK ranks #7 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
61,319 | $7,747,042 | |
| 2 | AZN |
Astrazeneca PLC
|
27,221 | $5,161,646 | |
| 3 | AMGN |
Amgen Inc
|
12,935 | $4,684,022 | |
| 4 | ABBV |
AbbVie Inc.
|
15,376 | $3,869,216 | |
| 5 | JNJ |
Johnson & Johnson
|
13,954 | $3,543,897 | |
| 6 | MRK |
Merck & Co., Inc.
|
25,475 | $3,273,537 | |
| 7 | GSK |
GSK plc
This page
|
59,214 | $3,103,997 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
52,522 | $3,026,317 |
All Filings in GSK
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,103,997 | 59,214 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,274,643 | 59,334 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,982,759 | 60,823 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,642,255 | 61,220 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,375,692 | 61,867 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,411,913 | 62,259 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,114,798 | 62,531 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $2,529,041 | 61,865 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,400,051 | 62,339 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,697,894 | 62,932 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,376,546 | 64,127 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $2,344,686 | 64,681 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,331,390 | 65,415 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,327,252 | 65,409 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $2,317,518 | 65,951 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,150,273 | 73,064 | Shares | Sole | 2022-11-15 | |
| 2022-03-31 | $3,974,666 | 93,032 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $4,187,306 | 96,809 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $3,541,479 | 94,499 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,623,955 | 92,790 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $3,226,668 | 92,178 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $3,324,566 | 92,110 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $3,418,912 | 92,610 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||